{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:57:05Z","timestamp":1794477425657,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research","award":["26713036"],"award-info":[{"award-number":["26713036"]}]},{"name":"Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research","award":["26461469"],"award-info":[{"award-number":["26461469"]}]},{"name":"Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research","award":["26461468"],"award-info":[{"award-number":["26461468"]}]},{"name":"Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research","award":["16K19085"],"award-info":[{"award-number":["16K19085"]}]},{"name":"Yokohama Foundation for Advancement of Medical Science"},{"name":"The Naito Memorial Foundation"},{"DOI":"10.13039\/100008732","name":"The Uehara Memorial Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Japan Intractable Diseases Research Foundation"},{"name":"Japan Rheumatic Disease Foundation"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1613-0","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T09:29:51Z","timestamp":1528795791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Hiroto","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9488-661X","authenticated-orcid":false,"given":"Yohei","family":"Kirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Higashitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuma","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"issue":"17","key":"1613_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Beh\u00e7et\u2019s disease. N Engl J Med. 1999;341(17):1284\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"1613_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ncprheum0436","volume":"3","author":"H Yazici","year":"2007","unstructured":"Yazici H, Fresko I, Yurdakul S. Beh\u00e7et\u2019s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3(3):148\u201355.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"7842","key":"1613_CR3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(73)93343-6","volume":"2","author":"S Ono","year":"1973","unstructured":"Ono S, Aoki K, Sugiura S, Nakayama E, Itakura K. Letter: HL-A5 and Beh\u00e7et\u2019s disease. Lancet. 1973;2(7842):1383\u20134.","journal-title":"Lancet"},{"issue":"8","key":"1613_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet. 2010;42(8):698\u2013702.","journal-title":"Nat Genet"},{"issue":"2","key":"1613_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202\u20137.","journal-title":"Nat Genet"},{"issue":"8","key":"1613_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"N Mizuki","year":"2010","unstructured":"Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et\u2019s disease susceptibility loci. Nat Genet. 2010;42(8):703\u20136.","journal-title":"Nat Genet"},{"issue":"3","key":"1613_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00439-012-1250-7","volume":"132","author":"H Li","year":"2013","unstructured":"Li H, Liu Q, Hou S, Du L, Zhou Q, Zhou Y, et al. TNFAIP3 gene polymorphisms confer risk for Beh\u00e7et\u2019s disease in a Chinese Han population. Hum Genet. 2013;132(3):293\u2013300.","journal-title":"Hum Genet"},{"issue":"3","key":"1613_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/annrheumdis-2013-204475","volume":"74","author":"JM Xavier","year":"2015","unstructured":"Xavier JM, Shahram F, Sousa I, Davatchi F, Matos M, Abdollahi BS, et al. FUT2: filling the gap between genes and environment in Beh\u00e7et\u2019s disease? Ann Rheum Dis. 2015;74(3):618\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1613_CR9","doi-asserted-by":"publisher","first-page":"e0119085","DOI":"10.1371\/journal.pone.0119085","volume":"10","author":"JH Kappen","year":"2015","unstructured":"Kappen JH, Medina-Gomez C, van Hagen PM, Stolk L, Estrada K, Rivadeneira F, et al. Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Beh\u00e7et disease. PLoS One. 2015;10(3):e0119085.","journal-title":"PLoS One"},{"issue":"3","key":"1613_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.3786","volume":"49","author":"M Takeuchi","year":"2017","unstructured":"Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Beh\u00e7et\u2019s disease susceptibility. Nat Genet. 2017;49(3):438\u201343.","journal-title":"Nat Genet"},{"issue":"7","key":"1613_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrrheum.2015.41","volume":"11","author":"Y Kirino","year":"2015","unstructured":"Kirino Y, Remmers EF. Genetic architectures of seropositive and seronegative rheumatic diseases. Nat Rev Rheumatol. 2015;11(7):401\u201314.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"1613_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","volume":"30","author":"BC Aridogan","year":"2003","unstructured":"Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S. Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-\u03b3 in Beh\u00e7et\u2019s disease. J Dermatol. 2003;30(8):602\u20137.","journal-title":"J Dermatol"},{"issue":"7","key":"1613_CR13","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/art.20334","volume":"50","author":"M Ben Ahmed","year":"2004","unstructured":"Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Beh\u00e7et\u2019s disease. Arthritis Rheum. 2004;50(7):2291\u20135.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1613_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.humimm.2013.11.009","volume":"75","author":"Z Wu","year":"2014","unstructured":"Wu Z, Zheng W, Xu J, Sun F, Chen H, Li P, et al. IL10 polymorphisms associated with Beh\u00e7et\u2019s disease in Chinese Han. Hum Immunol. 2014;75(3):271\u20136.","journal-title":"Hum Immunol"},{"issue":"3","key":"1613_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1189\/jlb.70.3.455","volume":"70","author":"EA de Wynter","year":"2001","unstructured":"de Wynter EA, Heyworth CM, Mukaida N, Jaworska E, Weffort-Santos A, Matushima K, et al. CCR1 chemokine receptor expression isolates erythroid from granulocyte-macrophage progenitors. J Leukoc Biol. 2001;70(3):455\u201360.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1613_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","volume":"41","author":"A Arida","year":"2011","unstructured":"Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Beh\u00e7et\u2019s disease: analysis of published data on 369 patients. Semin Arthritis Rheum. 2011;41(1):61\u201370.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"1613_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cyto.2003.09.003","volume":"24","author":"M Misumi","year":"2003","unstructured":"Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, et al. Cytokine production profile in patients with Beh\u00e7et\u2019s disease treated with infliximab. Cytokine. 2003;24(5):210\u20138.","journal-title":"Cytokine"},{"issue":"7","key":"1613_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"issue":"13","key":"1613_CR19","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1073\/pnas.0400983101","volume":"101","author":"FA Verreck","year":"2004","unstructured":"Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A. 2004;101(13):4560\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1613_CR20","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-04-4262","volume":"65","author":"C Guiducci","year":"2005","unstructured":"Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 2005;65(8):3437\u201346.","journal-title":"Cancer Res"},{"issue":"12","key":"1613_CR21","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/ndt\/gfw214","volume":"31","author":"N Endo","year":"2016","unstructured":"Endo N, Tsuboi N, Furuhashi K, Shi Y, Du Q, Abe T, et al. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis. Nephrol Dial Transplant. 2016;31(12):2023\u201333.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1613_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jdermsci.2013.11.001","volume":"73","author":"AK Anower","year":"2014","unstructured":"Anower AK, Shim JA, Choi B, Kwon HJ, Sohn S. The role of classical and alternative macrophages in the immunopathogenesis of herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci. 2014;73(3):198\u2013208.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"1613_CR23","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/ar2367","volume":"10","author":"Y Kirino","year":"2008","unstructured":"Kirino Y, Takeno M, Watanabe R, Murakami S, Kobayashi M, Ideguchi H, et al. Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Beh\u00e7et\u2019s disease. Arthritis Res Ther. 2008;10(1):R16.","journal-title":"Arthritis Res Ther."},{"issue":"8697","key":"1613_CR24","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet"},{"issue":"10","key":"1613_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320.","journal-title":"N Engl J Med"},{"issue":"3","key":"1613_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1309\/AJCP1TA3FLOQTMHF","volume":"133","author":"MW Anderson","year":"2010","unstructured":"Anderson MW, Zhao S, Ai WZ, Tibshirani R, Levy R, Lossos IS, et al. C-C chemokine receptor 1 expression in human hematolymphoid neoplasia. Am J Clin Pathol. 2010;133(3):473\u201383.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"1613_CR27","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1158\/1078-0432.CCR-05-2254","volume":"12","author":"IO Gordon","year":"2006","unstructured":"Gordon IO, Freedman RS. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients. Clin Cancer Res. 2006;12(5):1515\u201324.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1613_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889\u201396.","journal-title":"Nat Immunol"},{"issue":"7","key":"1613_CR29","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/ng.3885","volume":"49","author":"K Ishigaki","year":"2017","unstructured":"Ishigaki K, Kochi Y, Suzuki A, Tsuchida Y, Tsuchiya H, Sumitomo S, et al. Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis. Nat Genet. 2017;49(7):1120\u20135.","journal-title":"Nat Genet"},{"issue":"8","key":"1613_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/intimm\/dxf054","volume":"14","author":"A Corcione","year":"2002","unstructured":"Corcione A, Tortolina G, Bonecchi R, Battilana N, Taborelli G, Malavasi F, et al. Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells. Int Immunol. 2002;14(8):883\u201392.","journal-title":"Int Immunol"},{"issue":"4","key":"1613_CR31","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar3066","volume":"12","author":"N Higashi-Kuwata","year":"2010","unstructured":"Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, Muchemwa FC, et al. Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther. 2010;12(4):R128.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"1613_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/ng.221","volume":"40","author":"A Franke","year":"2008","unstructured":"Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008;40(11):1319\u201323.","journal-title":"Nat Genet"},{"issue":"21","key":"1613_CR33","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","volume":"361","author":"EO Glocker","year":"2009","unstructured":"Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361(21):2033\u201345.","journal-title":"N Engl J Med"},{"issue":"12","key":"1613_CR34","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00439-012-1200-4","volume":"131","author":"S Hou","year":"2012","unstructured":"Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P. Two-stage association study in Chinese Han identifies two independent associations in CCR1\/CCR3 locus as candidate for Beh\u00e7et\u2019s disease susceptibility. Hum Genet. 2012;131(12):1841\u201350.","journal-title":"Hum Genet"},{"key":"1613_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","volume":"64","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Beh\u00e7et\u2019s disease: a comprehensive review. J Autoimmun. 2015;64:137\u201348.","journal-title":"J Autoimmun"},{"issue":"3","key":"1613_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nm0302-240","volume":"8","author":"TS Lee","year":"2002","unstructured":"Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8(3):240\u20136.","journal-title":"Nat Med"},{"key":"1613_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.abb.2014.09.005","volume":"564","author":"Y Naito","year":"2014","unstructured":"Naito Y, Takagi T, Higashimura Y. Heme oxygenase-1 and anti-inflammatory M2 macrophages. Arch Biochem Biophys. 2014;564:83\u20138.","journal-title":"Arch Biochem Biophys"},{"issue":"20","key":"1613_CR38","doi-asserted-by":"publisher","first-page":"8134","DOI":"10.1073\/pnas.1306352110","volume":"110","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Beh\u00e7et disease. Proc Natl Acad Sci U S A. 2013;110(20):8134\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1613_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1096\/fj.15-281329","volume":"30","author":"KH Han","year":"2016","unstructured":"Han KH, Gonzalez-Quintial R, Peng Y, Baccala R, Theofilopoulos AN, Lerner RA. An agonist antibody that blocks autoimmunity by inducing anti-inflammatory macrophages. FASEB J. 2016;30(2):738\u201347.","journal-title":"FASEB J"},{"issue":"4","key":"1613_CR40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1159\/000430251","volume":"37","author":"F Li","year":"2015","unstructured":"Li F, Yang Y, Zhu X, Huang L, Xu J. Macrophage polarization modulates development of systemic lupus erythematosus. Cell Physiol Biochem. 2015;37(4):1279\u201388.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"1613_CR41","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/art.22370","volume":"56","author":"Y Kirino","year":"2007","unstructured":"Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, et al. Tumor necrosis factor \u03b1 acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum. 2007;56(2):464\u201375.","journal-title":"Arthritis Rheum"},{"issue":"16","key":"1613_CR42","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","volume":"372","author":"G Hatemi","year":"2015","unstructured":"Hatemi G, Melikoglu M, Tunc R, Korkmaz C, Turgut Ozturk B, Mat C, et al. Apremilast for Beh\u00e7et\u2019s syndrome\u2014a phase 2, placebo-controlled study. N Engl J Med. 2015;372(16):1510\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"1613_CR43","doi-asserted-by":"publisher","first-page":"e10693","DOI":"10.1371\/journal.pone.0010693","volume":"5","author":"T Zeller","year":"2010","unstructured":"Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, et al. Genetics and beyond \u2013 the transcriptome of human monocytes and disease susceptibility. PLoS One. 2010;5(5):e10693.","journal-title":"PLoS One"},{"key":"1613_CR44","doi-asserted-by":"crossref","unstructured":"Hughes T, Ture-Ozdemir F, Alibaz-Oner F, Coit P, Direskeneli H, Sawalha AH. Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behcet's disease, Arthritis Rheumatol. 2014;66(6):1648\u20131658.","DOI":"10.1002\/art.38409"},{"key":"1613_CR45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fimmu.2014.00432","volume":"5","author":"M Hilhorst","year":"2014","unstructured":"Hilhorst M, Shirai T, Berry G, Goronzy JJ, Weyand CM. T cell-macrophage interactions and granuloma formation in vasculitis. Front Immunol. 2014;5:432.","journal-title":"Front Immunol"},{"issue":"3","key":"1613_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/ar757","volume":"5","author":"S Hirohata","year":"2003","unstructured":"Hirohata S, Kikuchi H. Beh\u00e7et\u2019s disease. Arthritis Res Ther. 2003;5(3):139\u201346.","journal-title":"Arthritis Res Ther."}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1613-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1613-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1613-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:24:57Z","timestamp":1693700697000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1613-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1613-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol and genetic analyses were approved by Yokohama City University Ethics Board (A140327015 and B131107009). All of the human samples were used after written informed consent was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"MT serves as an advisor for the apremilast clinical trial for Celgene.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"124"}}